Topics

risk factors

8 in 10 People Who Have Died of COVID-19 Were Age 65 or Older – But the Share Varies By State
Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
Body Mass Index and Risk for COVID-19–Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death — United States, March–December 2020
Characteristics and Clinical Outcomes of Children and Adolescents Aged less than 18 Years Hospitalized with COVID-19, 6 Hospitals, United States, July-August 2021
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Characteristics and predictors of Long COVID among diagnosed cases of COVID-19
Children and young people remain at low risk of COVID-19 mortality
COVID-19 confirmed deaths in England r(to 31 January 2021): report
Covid-19-Navigating the Uncharted
Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries
Excess Weight and COVID-19: Insights from new evidence
Freedom of Information (FOI) request: COVID-19 deaths and autopsies Feb 2020 to Dec 2021
Immunocompromised children and young people are at no increased risk of severe COVID-19
Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden—A cohort study
Independent report: JCVI statement on vaccination of children aged 5 to 11 years old
Letter to the Editor: Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden
Letter to the Editor: Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response
Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity
Nearly 90% of People Hospitalized for COVID-19 Have Underlying Conditions, Says CDC
On the use of the Pfizer and the Moderna COVID-19 mRNA vaccines in children and adolescents
Physicians Declaration II
Position Statement on COVID-19 Vaccines for Children
QCovid algorithm
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS -CoV-2 infection in Germany
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Risk of severe COVID-19 infection among adults with prior exposure to children
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study
Statistics of the COVID-19 pandemic in the United States
Studies on Covid-19 Lethality
Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021
Vitamin D: A key player in COVID‑19 immunity and lessons from the pandemic to combat immune‑evasive variants
Weekly Updates by Select Demographic and Geographic Characteristics - Provisional Death Counts for Coronavirus Disease 2019 (COVID-19)
Why are we vaccinating children against COVID-19?
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
1654